Medicare Advantage Plans Face Continued Contraction With Millions Forced to Switch Coverage
Medicare Advantage plan offerings will decline modestly from 5,553 to 5,532 between 2026 and 2027, but underlying shifts reveal significant disruption with 181 counties losing all plan options and approximately 3.8 million enrollees required to select new coverage due to plan terminations. Major insurers including HCSC, Centene, and United are substantially reducing their product portfolios, while prescription drug coverage options within MA plans are declining by 8 percent. Despite industry investments, specialized dual eligible and chronic care plans are experiencing net reductions overall.
The Medicare Advantage sector is experiencing significant operational consolidation heading into 2027. While the headline count of available plans appears stable, this masks substantial underlying volatility characterized by major carriers substantially shrinking their product lineups. HCSC leads these reductions with nearly 500 fewer offerings, followed by Centene and United with hundreds of plan eliminations each. Geographic coverage gaps are widening considerably, with counties lacking any plan options nearly tripling year-over-year.
The contraction extends to specialized coverage categories. Prescription drug plan options integrated with Medicare Advantage are declining notably, and despite prior industry investments in targeted programs for high-need populations, dual-eligible and chronic care specialized plans are contracting overall rather than expanding.
This consolidation could create significant administrative burden for millions of enrollees who must actively select replacement coverage, a process that may result in coverage lapses or suboptimal plan matching for vulnerable populations. Geographic deserts without plan options may limit choices for beneficiaries in affected counties. The reduction in prescription drug coverage options within MA plans could complicate medication access for enrollees. However, some contraction may reflect market rationalization, and increased chronic care plans partially offset losses in other specialized categories.